Vencanna Ventures Inc. (CSE:VENI)
Canada
· Delayed Price · Currency is CAD 0.0050
0.00 (0.00%)
Feb 4, 2026, 9:34 AM EST
Vencanna Ventures Revenue
Vencanna Ventures had revenue of $413.52K USD in the quarter ending October 31, 2025, a decrease of -64.36%. This brings the company's revenue in the last twelve months to $2.57M, up 6.53% year-over-year. In the fiscal year ending April 30, 2025, Vencanna Ventures had annual revenue of $4.01M.
Revenue (ttm)
$2.57M
Revenue Growth
+6.53%
P/S Ratio
0.31
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.11M CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2025 | 4.01M | - | - |
| Apr 30, 2024 | - | - | - |
| Dec 31, 2023 | 10.06M | -715.30K | -6.64% |
| Dec 31, 2022 | 10.77M | -3.37M | -23.82% |
| Dec 31, 2021 | 14.14M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Adastra Holdings | 16.86M |
| Genix Pharmaceuticals | 68.00 |
| Ovation Science | 63.82K |
| Captor Capital | -32.22M |
| Aequus Pharmaceuticals | 918.47K |
| Ayurcann Holdings | 31.28M |